Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction

Liu Zhijian; Hu Gaopin; Fei Meiying; Yin Zao; Shi Quanxing; Sun Fei

doi:10.24920/11810

Your Location：

Home >

Browse articles >

Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction

Chinese Medical Sciences Journal Vol. 33, Issue 2, Pages: 84-90(2018)

Original Article | Updated：2024-04-10

- Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction
- Affiliations：
  
  1 Department of Cardiology, the 210th Hospital of People’s Liberation Army, Dalian, Liaoning 116021, China;
  2 Department of Cardiology, the 306th Hospital of People’s Liberation Army, Beijing 100101, China;
- Author bio：
- Funds：
- DOI：10.24920/11810
  CLC：
- Received：07 November 2017，
  
  Published Online：20 June 2018，
  
  Published：20 June 2018
- Accepted：
Scan QR Code
Liu Zhijian, Hu Gaopin, Fei Meiying, et al. Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction[J]. Chinese medical sciences journal, 2018, 33(2): 84-90.
DOI：

Liu Zhijian, Hu Gaopin, Fei Meiying, et al. Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction[J]. Chinese medical sciences journal, 2018, 33(2): 84-90. DOI： 10.24920/11810.

摘要

目的

评估短期大剂量阿托伐他汀治疗对初发前壁心肌梗死患者高敏C反应蛋白（hs-CRP）

丙二醛（MDA）、内皮素（ET-1）

基质金属蛋白酶（MMPs）及左心室重构的影响。

方法

103例成功施行经皮冠脉介入治疗（PCI）的初发前壁心肌梗死的住院患者随机分为两组：强化治疗组（n=49）入院后即给予阿托伐他汀40mg/日

维持1周

其后给予20mg/日;标准治疗组（n=54）给予阿托伐他汀20mg/日。在入院时、发病1周、2周及6个月随访时分别检测血浆hs-CRP

MDA

ET-1

MMP-2 和 MMP-9水平。在入院时、发病2周及1年随访时分别进行彩色超声心动检查评估左室舒张末容积（LVEDV）、左室收缩末容积（LVESV）和左室射血分数（LVEF）。比较上述实验室指标和左心室重构指标在强化治疗组和标准治疗组之间的差异。

结果

在心肌梗死发病后一周时强化治疗组血浆 hs-CRP（F=7.718

=0.009）、ET-1（

=7.882

=0.006）、MMP-9（F=4.834

=0.028）和pro-BNP(

=4.603

=0.032)的浓度明显低于标准治疗组;随访1年时两组患者的左室重构指标LVEDV（

=0.722

=0.444）

LVESV（

=1.228

=0.221）和LVEF（

=1.354

=0.187）值无明显差异。

结论

心肌梗死后给予短期大剂量阿托伐他汀可以有效降低血中hs-CRP、ET-1和MMP-9的水平

但对左室重构并无明显影响。

Abstract

Objects

The aim of this trial was to evaluate the effect of short-term high-dose atorvastatin therapy on levels of high-sensitivity C-reactive protein (hs-CRP)

malonaldehyde (MDA)

endothelin-1(ET-1)

matrix metalloproteinases (MMPs)

and left ventricular (LV) remodeling in patients with first time attack of acute anterior myocardial infarction (AAMI) .

Methods

A hundred and three patients with first time attack of AAMI who underwent successful primary percutaneous coronary intervention were randomized to receive atorvastatin 40 mg once daily for 1 week followed by 20 mg once daily (intensive treatment group

IT group

=49)

or atorvastatin 20 mg once daily (standard treatment group

ST group

=54). Plasma levels of hs-CRP

MDA

ET-1

MMP-2 and MMP-9 were measured on admission

at 1 week

2 weeks and 6 months follow up and compared between the IT group and ST group. Echocardiography was performed on admission

at 2 week

and 1 year follow up. The left ventricular end-diastolic volume (LVEDV)

left ventricular end-systolic volume (LVESV) and left ventricular ejection fraction (LVEF) were measured at each echocardiographic examination and compared between the IT group and ST group.

Results

Plasma levels of hs-CRP (

=7.718

=0.009)

ET-1 (

=7.882

=0.006)

MMP-9 (

=4.834

=0.028) and pro-BNP (

=4.603

=0.032) were significantly lower at 1 week after initial onset of AAMI in the IT group compared with the ST group. The changes of LVEDV

LVESV

and LVEF at the 1 year follow-up from the admission did not differ between the IT group and the ST group (

=0.722

=0.444;

=1.228

=0.221;

=1.354

=0.187

repectively).

Conclusions

Short-term high-dose atorvastatin treatment for AAMI was associated with lower hs-CRP

ET-1 and MMP-9 levels compared to the standard dose treatment. However

this beneficial effect is not likely to related to the left ventricular remodeling.

关键词

Keywords

references

Gajarsa JJ , Kloner RA . Left ventricular remodeling in the post-infarction heart: A review of cellular, molecular mechanisms, and therapeutic modalities . Heart Fail Rev 2011 ; 16 ( 1 ): 13 - 21 . doi: 10.1007/s10741-010-9181-7 10.1007/s10741-010-9181-7 . DOI: 10.1007/s10741-010-9181-7 http://doi.org/10.1007/s10741-010-9181-7 http://link.springer.com/10.1007/s10741-010-9181-7 http://link.springer.com/10.1007/s10741-010-9181-7

Westman PC , Lipinski MJ , Luger D , et al . Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction . J Am Coll Cardiol 2016 ; 67 ( 17 ): 2050 - 60 . doi: 10.1016/j.jacc.2016.01.073 10.1016/j.jacc.2016.01.073 . DOI: 10.1016/j.jacc.2016.01.073 http://doi.org/10.1016/j.jacc.2016.01.073 http://www.sciencedirect.com/science/article/pii/S0735109716008226 http://www.sciencedirect.com/science/article/pii/S0735109716008226

Nilsson L , Hallén J , Atar D , et al . Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction . Heart 2012 ; 98 ( 1 ): 31 - 6 . doi: 10.1136/heartjnl-2011-300079 10.1136/heartjnl-2011-300079 . DOI: 10.1136/heartjnl-2011-300079 http://doi.org/10.1136/heartjnl-2011-300079 http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2011-300079 http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2011-300079

van Klei WA , Buhre WF . Anti-inflammatory effects of perioperative statin therapy . Can J Anaesth 2012 ; 59 ( 6 ): 516 - 21 . doi: 10.1007/s12630-012-9703-y 10.1007/s12630-012-9703-y . DOI: 10.1007/s12630-012-9703-y http://doi.org/10.1007/s12630-012-9703-y http://link.springer.com/10.1007/s12630-012-9703-y http://link.springer.com/10.1007/s12630-012-9703-y

Oesterle A , Laufs U , Liao JK . Pleiotropic effects of statins on the cardiovascular system . Circ Res 2017 ; 120 ( 1 ): 229 - 43 . doi: 10.1161/CIRCRESAHA.116.308537 10.1161/CIRCRESAHA.116.308537 . DOI: 10.1161/CIRCRESAHA.116.308537 http://doi.org/10.1161/CIRCRESAHA.116.308537 http://circres.ahajournals.org/lookup/doi/10.1161/CIRCRESAHA.116.308537 http://circres.ahajournals.org/lookup/doi/10.1161/CIRCRESAHA.116.308537

Mao Y , Koga JI , Tokutome M , et al . Nanoparticle-mediated delivery of pitavastatin to monocytes/macrophages inhibits left ventricular remodeling after acute myocardial infarction by inhibiting monocyte-mediated inflammation . Int Heart J 2017 ; 58 ( 4 ): 615 - 23 . doi: 10.1536/ihj.16-457 10.1536/ihj.16-457 . DOI: 10.1536/ihj.16-457 http://doi.org/10.1536/ihj.16-457 https://www.jstage.jst.go.jp/article/ihj/58/4/58_16-457/_article https://www.jstage.jst.go.jp/article/ihj/58/4/58_16-457/_article

Shirakabe A , Asai K , Hata N , et al . Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure . J Cardiol 2012 ; 59 ( 3 ): 374 - 82 . doi: 10.1016/j.jjcc.2012.01.009 10.1016/j.jjcc.2012.01.009 . DOI: 10.1016/j.jjcc.2012.01.009 http://doi.org/10.1016/j.jjcc.2012.01.009 http://linkinghub.elsevier.com/retrieve/pii/S0914508712000159 http://linkinghub.elsevier.com/retrieve/pii/S0914508712000159

Ansheles AA , Rvacheva AV , Sergienko IV . Effect of atorvastatin therapy on the level of CD34+CD133+CD309+ endothelial progenitor cells in patients with coronary heart disease . Bull Exp Biol Med 2017 ; 163 ( 1 ): 133 - 6 . doi: 10.1007/s10517-017-3753-7 10.1007/s10517-017-3753-7 . DOI: 10.1007/s10517-017-3753-7 http://doi.org/10.1007/s10517-017-3753-7 http://link.springer.com/10.1007/s10517-017-3753-7 http://link.springer.com/10.1007/s10517-017-3753-7

Sahebkar A , Kotani K , Serban C , et al . Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials . Atherosclerosis 2015 ; 241 ( 2 ): 433 - 42 . doi: 10.1016/j.atherosclerosis.2015.05.022 10.1016/j.atherosclerosis.2015.05.022 . DOI: 10.1016/j.atherosclerosis.2015.05.022 http://doi.org/10.1016/j.atherosclerosis.2015.05.022 http://linkinghub.elsevier.com/retrieve/pii/S0021915015013362 http://linkinghub.elsevier.com/retrieve/pii/S0021915015013362

Ishida K , Geshi T , Nakano A , et al . Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction . Int J Cardiol 2012 ; 155 ( 3 ): 442 - 7 . doi: 10.1016/j.ijcard.2011.11.015 10.1016/j.ijcard.2011.11.015 . DOI: 10.1016/j.ijcard.2011.11.015 http://doi.org/10.1016/j.ijcard.2011.11.015 http://linkinghub.elsevier.com/retrieve/pii/S0167527311020687 http://linkinghub.elsevier.com/retrieve/pii/S0167527311020687

Rebic D , Rasic S , Rebic V . Influence of endothelin-1 and nitric oxide on left ventricular remodeling in patients on peritoneal dialysis . Ren Fail 2014 ; 36 ( 2 ): 232 - 6 . doi: 10.3109/0886022X.2013.836935 10.3109/0886022X.2013.836935 . DOI: 10.3109/0886022X.2013.836935 http://doi.org/10.3109/0886022X.2013.836935 http://www.tandfonline.com/doi/full/10.3109/0886022X.2013.836935 http://www.tandfonline.com/doi/full/10.3109/0886022X.2013.836935

Lee BK , Koo BK , Nam CW , et al . Does Pre-treatment with high dose atorvastatin prevent microvascular dysfunction after percutaneous coronary intervention in patients with acute coronary syndrome? Korean Circ J 2016 ; 46 ( 4 ): 472 - 80 . doi: 10.4070/kcj.2016.46.4.472 10.4070/kcj.2016.46.4.472 . DOI: 10.4070/kcj.2016.46.4.472 http://doi.org/10.4070/kcj.2016.46.4.472 https://synapse.koreamed.org/DOIx.php?id=10.4070/kcj.2016.46.4.472 https://synapse.koreamed.org/DOIx.php?id=10.4070/kcj.2016.46.4.472

Masci PG , Ganame J , Francone M , et al . Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling . Eur Heart J 2011 ; 32 ( 13 ): 1640 - 8 . doi: 10.1093/eurheartj/ehr064 10.1093/eurheartj/ehr064 . DOI: 10.1186/1532-429X-13-S1-P84 http://doi.org/10.1186/1532-429X-13-S1-P84 https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehr064 https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehr064

Schiller NB , Shah PM , Crawford M , et al . Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms . J Am Soc Echocardiogr 1989 ; 2 ( 5 ): 358 - 67 . doi: 10.1016/s0894-7317(89)80014-8 10.1016/s0894-7317(89)80014-8 . DOI: 10.1016/S0894-7317(89)80014-8 http://doi.org/10.1016/S0894-7317(89)80014-8 http://linkinghub.elsevier.com/retrieve/pii/S0894731789800148 http://linkinghub.elsevier.com/retrieve/pii/S0894731789800148

Casas JP , Shah T , Hingorani AD , et al . C-reactive protein and coronary heart disease: a critical review . J Intern Med 2008 ; 264 ( 4 ): 295 - 314 . doi: 10.1111/j.1365-2796.2008.02015.x 10.1111/j.1365-2796.2008.02015.x . DOI: 10.1111/j.1365-2796.2008.02015.x http://doi.org/10.1111/j.1365-2796.2008.02015.x http://blackwell-synergy.com/doi/abs/10.1111/jim.2008.264.issue-4 http://blackwell-synergy.com/doi/abs/10.1111/jim.2008.264.issue-4

Takahashi T , Anzai T , Kaneko H , et al . Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction . Am J Physiol Heart Circ Physiol 2010 ; 299 ( 6 ): H1795 - 1804 . doi: 10.1152/ajpheart.00001.2010 10.1152/ajpheart.00001.2010 . DOI: 10.1152/ajpheart.00001.2010 http://doi.org/10.1152/ajpheart.00001.2010 http://www.physiology.org/doi/10.1152/ajpheart.00001.2010 http://www.physiology.org/doi/10.1152/ajpheart.00001.2010

Tousoulis D , Oikonomou E , Siasos G , et al . Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure . Atherosclerosis 2013 ; 227 ( 2 ): 367 - 72 . doi: 10.1016/j.atherosclerosis.2013.01.015 10.1016/j.atherosclerosis.2013.01.015 . DOI: 10.1016/j.atherosclerosis.2013.01.015 http://doi.org/10.1016/j.atherosclerosis.2013.01.015 http://linkinghub.elsevier.com/retrieve/pii/S0021915013000506 http://linkinghub.elsevier.com/retrieve/pii/S0021915013000506

DeLeon-Pennell KY , Meschiari CA , Jung M , et al . Matrix Metalloproteinases in Myocardial Infarction and Heart Failure . Prog Mol Biol Transl Sci 2017 ; 147 : 75 - 100 . doi: 10.1016/bs.pmbts.2017.02.001 10.1016/bs.pmbts.2017.02.001 . DOI: 10.1016/bs.pmbts.2017.02.001 http://doi.org/10.1016/bs.pmbts.2017.02.001 http://linkinghub.elsevier.com/retrieve/pii/S1877117317300169 http://linkinghub.elsevier.com/retrieve/pii/S1877117317300169

Wang J , Tan GJ , Han LN , et al . Novel biomarkers for cardiovascular risk prediction . J Geriatr Cardiol 2017 ; 14 ( 2 ): 135 - 50 . doi: 10.11909/j.issn.1671-5411.2017.02.008 10.11909/j.issn.1671-5411.2017.02.008 . DOI: 10.11909/j.issn.1671-5411.2017.02.008 http://doi.org/10.11909/j.issn.1671-5411.2017.02.008 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409355/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409355/

Views

970

Downloads

CSCD

Alert me when the article has been cited

Submit

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰